Should we be combining local tumor therapies with immunotherapies as standard?

被引：3
|
作者：
Baues, Christian [1 ,2 ,3 ]
Schlaak, Max [1 ,4 ]
von Bergwelt-Baildon, Michael [1 ,5 ,6 ]
Theurich, Sebastian [1 ,5 ,7 ]
机构：
[1] Univ Hosp Cologne, Radio Immune Oncol RIO Consortium, Cologne, Germany
[2] Univ Hosp Cologne, Dept Radio Oncol, Cologne, Germany
[3] Univ Hosp Cologne, CyberKnife Ctr, Cologne, Germany
[4] Univ Hosp Cologne, Skin Canc Ctr, Dept Dermatol & Venereol, Cologne, Germany
[5] Univ Hosp Cologne, Ctr Integrated Oncol CIO Koln Bonn, Dept Internal Med, Cologne, Germany
[6] Univ Hosp Cologne, Dept Internal Med, CII, Cologne, Germany
[7] Univ Hosp Cologne, Dept Internal Med, Canc & Immunometab Res Grp, Cologne, Germany
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 18期
关键词：
abscopal effect; CTLA4; electrochemotherapy; immune checkpoint inhibition; immunogenic cell death; immunotherapy; ipilimumab; local treatment; nivolumab; PD-1; pembrolizumab; radiotherapy; talimogene laherparepvec; T-VEC; ADVANCED MELANOMA; UNTREATED MELANOMA; RADIATION-THERAPY; IPILIMUMAB; NIVOLUMAB; SURVIVAL; RADIOTHERAPY; COMBINATION;
D O I：
10.2217/fon-2017-0150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1573 / 1575
页数：3
相关论文
共 50 条
  • [41] Imaging after Local Tumor Therapies: Kidney and Liver
    Kielar, Ania Z.
    Hibbert, Rebecca M.
    Maturen, Katherine E.
    SEMINARS IN ROENTGENOLOGY, 2013, 48 (03) : 273 - 284
  • [42] Local Anti-angiogenic Brain Tumor Therapies
    Eric P. Sipos
    Henry Brem
    Journal of Neuro-Oncology, 2000, 50 : 181 - 188
  • [43] Local anti-angiogenic brain tumor therapies
    Sipos, EP
    Brem, H
    JOURNAL OF NEURO-ONCOLOGY, 2000, 50 (1-2) : 181 - 188
  • [44] Maintenance Therapies in Indolent Lymphomas: should Recent Data Change the Standard of Care?
    Tees, Michael T.
    Flinn, Ian W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (03)
  • [45] Maintenance Therapies in Indolent Lymphomas: should Recent Data Change the Standard of Care?
    Michael T. Tees
    Ian W. Flinn
    Current Treatment Options in Oncology, 2017, 18
  • [46] ENHANCED TUMOR RESPONSES THROUGH THERAPIES COMBINING CCNU, MISO AND RADIATION
    SIEMANN, DW
    HILL, SA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09): : 1623 - 1626
  • [47] Assessing the impact of immunotherapies and cell therapies in 3D heterospheroid models mimicking tumor microenvironments
    Madsen, Natasha Helleberg
    Nielsen, Boye Schnack
    Holmstrom, Kim
    Olofsson, Gitte
    Straten, Per Thor
    Skov, Soren
    Rodriguez-Pardo, Carlos
    Ormhoj, Maria
    Larsen, Jesper
    Gad, Monika
    CANCER RESEARCH, 2024, 84 (06)
  • [48] Noninvasive Brain Stimulation Therapies to Promote Recovery of Consciousness: Where We Are and Where We Should Go
    Barra, Alice
    Monti, Martin
    Thibaut, Aurore
    SEMINARS IN NEUROLOGY, 2022, 42 (03) : 348 - 362
  • [49] Cut to the chase: Should we use tumor microarrays to evaluate the tumor microenvironment?
    Lara, O. D.
    Lyons, Y. A.
    Dood, R. L.
    Wang, Z.
    Pradeep, S.
    Sood, A. K.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 59 - 59
  • [50] Standard treatment in anal cancer: where do we stand and where should we go?
    Muirhead, R.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S250 - S250
12345